Long-term evaluation of the effectiveness and safety of autologous haematopoietic stem-cell transplantation for systemic sclerosis (NISSC1-LTE): a cohort study
Long-term evaluation of the effectiveness and safety of autologous haematopoietic stem-cell transplantation for systemic sclerosis (NISSC1-LTE): a cohort study. // The Lancet Rheumatology. – URL: https://www.sciencedirect.com/science/article/pii/S2665991326002274?dgcid=rss_sd_all
Long-term evaluation of the effectiveness and safety of autologous haematopoietic stem-cell transplantation for systemic sclerosis (NISSC1-LTE): a cohort study. The Lancet Rheumatology. https://www.sciencedirect.com/science/article/pii/S2665991326002274?dgcid=rss_sd_all
“Long-term evaluation of the effectiveness and safety of autologous haematopoietic stem-cell transplantation for systemic sclerosis (NISSC1-LTE): a cohort study.” The Lancet Rheumatology.
@article{article69349,
title = {Long-term evaluation of the effectiveness and safety of autologous haematopoietic stem-cell transplantation for systemic sclerosis (NISSC1-LTE): a cohort study},
journal = {The Lancet Rheumatology},
url = {https://www.sciencedirect.com/science/article/pii/S2665991326002274?dgcid=rss_sd_all}
}